In a 6 year follow-up study of 400 women with planned pregnancies, it was found that patients with higher plasma levels of lncRNA MEG8 prior to pregnancy had a higher incidence of GDM during pregnancy. This evidence concerns the gene MEG8 and gestational diabetes.